kisqali news - Search News

FDA expands approval of breast cancer drug Kisqali

UPI on MSN · 2d

FDA expands use of Kisqali to early stage breast cancer patients

Women with early stage breast cancer may now take Kisqali, a medication already approved for advanced disease.

scrippsnews · 1d

Breast cancer drug Kisqali gets FDA approval to prevent cancer recurrence

The breast cancer drug Kisqali has received FDA approval to reduce cases of cancer recurrence. The drug was found to reduce the chances of a patient's breast cancer coming back by 25%.

NBC News on MSN · 2d

FDA expands approval of breast cancer drug Kisqali to earlier stage patients

The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease, drugmaker Novartis said Tuesday.

Lilly on alert as new Kisqali approval threatens Verzenio

Verzenio was approved for a similar adjuvant indication last year, having been used for a couple of years only in patients ...

Hosted on MSN3d

Novartis’ breast cancer trial of Kisqali reveals 28.5% risk reduction

Kisqali is a selective cyclin-dependent kinase inhibitor that targets proteins involved in the rapid division of cancer cells ...

2d

Novartis’ Kisqali gets expanded FDA OK; Mene Pangalos joins Omega Funds

The FDA’s clearance could double Kisqali’s breast cancer market. Elsewhere, Novo is exploring new ways to deliver genetic ...

2d

Novartis AG: Hold Rating Justified Amid Kisqali’s Market Potential and FDA Approval

Analyst Eric Le Berrigaud from Stifel Nicolaus maintained a Hold rating on Novartis AG (NOVN – Research Report) and keeping the price ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results